Enokizumab (MEDI-528) is a monoclonal antibody specifically designed to target interleukin-9 (IL-9). IL-9 plays a critical role in regulating various pathological processes in the respiratory system, including airway inflammation, mucus production, airway hyperresponsiveness, and fibrosis. This regulation is primarily mediated through the proliferation and activation of mast cells within the airways. Enokizumab's mechanism of action focuses on neutralizing IL-9, thereby potentially mitigating its effects on these respiratory conditions. This antibody is pivotal for research focused on the pathophysiology of respiratory diseases and the development of targeted therapies.
Enokizumab (MEDI-528) is a monoclonal antibody specifically designed to target interleukin-9 (IL-9). IL-9 plays a critical role in regulating various pathological processes in the respiratory system, including airway inflammation, mucus production, airway hyperresponsiveness, and fibrosis. This regulation is primarily mediated through the proliferation and activation of mast cells within the airways. Enokizumab's mechanism of action focuses on neutralizing IL-9, thereby potentially mitigating its effects on these respiratory conditions. This antibody is pivotal for research focused on the pathophysiology of respiratory diseases and the development of targeted therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
